Skin Cancer - Cutaneous Lymphomas

Skin Cancer - Cutaneous Lymphomas PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Skin Cancer: Understanding Cutaneous Lymphomas
Cutaneous lymphomas are rare forms of non-Hodgkin lymphomas that originate in the skin. They are classified into two main types: Cutaneous T-cell Lymphomas (CTCL), which includes Mycosis Fungoides and Sézary Syndrome, and Cutaneous B-cell Lymphomas (CBCL), such as Primary Cutaneous Marginal Zone Lymphoma. CTCL is the most common, accounting for the majority of cases.
Patients may present with red patches, plaques, tumors, or persistent itching. In advanced stages, systemic symptoms like swollen lymph nodes and blood abnormalities may occur, particularly in Sézary Syndrome. Diagnosing cutaneous lymphomas involves clinical evaluation, skin biopsies, blood tests, and imaging to determine the disease’s extent and subtype.
Treatment depends on the stage and type and may include localized therapies such as phototherapy and radiation, as well as systemic options like immunotherapy, targeted therapy, or chemotherapy. Emerging treatments, including CAR-T cell therapy, are offering new hope for resistant cases.
Ongoing research is focused on personalized medicine and improving outcomes for patients. With early diagnosis and appropriate care, many cutaneous lymphomas can be effectively managed, improving patients' quality of life.
Awareness and innovation are key to addressing these rare but impactful skin cancers.

Tags : Cutaneous lymphomas, skin cancer, Mycosis Fungoides, Sézary Syndrome, diagnosis, treatment, phototherapy, T-cell lymphoma, B-cell lymphoma

Published on : Dec 03, 2024 | Views : 1965 | Downloads : 0

Shareable Url :

Awareness and innovation are key to addressing these rare but impactful skin cancers. - See more at: https://www.medicpresents.com/medical-powerpoint-presentations/skin-cancer-cutaneous-lymphomas/7090.html#sthash.80uO245k.dpuf&source=' title='Share on Linkedin'>

Embed Code :

Comment

Transcript

Slide 1-

Skin Cancer - Cutaneous Lymphomas Dr. Vineeta Bose Oncologist & Hematologist Diagnosis, Types, and Management
Slide 2-

What are Cutaneous Lymphomas? Rare non-Hodgkin lymphomas originating in the skin. Two main types: Cutaneous T-cell Lymphomas (CTCL). Cutaneous B-cell Lymphomas (CBCL). CTCL accounts for the majority of cases. Speaker's Note: Cutaneous lymphomas are unique because they start in the skin but may later affect internal organs. Understanding their types is key to management. Reference: World Health Organization (WHO). Classification of Skin Lymphomas.
Slide 3-

Types of Cutaneous Lymphomas Cutaneous T-cell Lymphomas (CTCL): Mycosis Fungoides (MF). Sézary Syndrome. Cutaneous B-cell Lymphomas (CBCL): Primary Cutaneous Marginal Zone Lymphoma. Primary Cutaneous Diffuse Large B-cell Lymphoma. Speaker's Note: Mycosis Fungoides is the most common subtype of CTCL, while CBCL is less frequent but equally important to identify. Reference: European Dermatology Forum. Guidelines on Primary Cutaneous Lymphomas.
Slide 4-

How Do Cutaneous Lymphomas Present? Red patches, plaques, or tumors on the skin. Persistent itching (pruritus). In Sézary Syndrome: Skin redness, swollen lymph nodes, and atypical lymphocytes in the blood. Speaker's Note: Symptoms can mimic other skin conditions like eczema, often delaying diagnosis. Early recognition is vital. Reference: National Comprehensive Cancer Network (NCCN). Cutaneous Lymphoma Clinical Features.
Slide 5-

Diagnosis of Cutaneous Lymphomas Clinical Exam: Evaluating skin lesions. Skin Biopsy: Confirming malignancy. Blood Tests: Sézary cells in Sézary Syndrome. Imaging: Staging with PET/CT scans. Immunophenotyping: Identifying specific lymphoma markers (e.g., CD4, CD8). Speaker's Note: Diagnosis requires a multidisciplinary approach, combining clinical observation with advanced tests. Reference: American Academy of Dermatology. Diagnosis of Cutaneous Lymphomas.
Slide 6-

Managing Cutaneous Lymphomas Localized Treatments: Topical steroids and retinoids. Phototherapy (e.g., PUVA). Radiation therapy. Systemic Treatments: Immunotherapy (e.g., interferons). Targeted therapy (e.g., brentuximab vedotin). Chemotherapy for advanced cases. Emerging Therapies: CAR-T cell therapy. Speaker's Note: Treatment depends on the stage and subtype. Advances like CAR-T therapy offer hope for refractory cases. Reference: Journal of the American Medical Association (JAMA). Advances in Cutaneous Lymphoma Therapies.
Slide 7-

Prognosis and Outcomes Prognosis varies by subtype and stage. Mycosis Fungoides: Generally slow progression. Sézary Syndrome: Aggressive with systemic involvement. Importance of follow-ups for recurrence monitoring. Speaker's Note: Prognosis is favorable for many with early-stage disease, but aggressive subtypes require vigilant management. Reference: Leukemia & Lymphoma Society. Survival Statistics for Skin Lymphomas.
Slide 8-

Innovations in Cutaneous Lymphoma Management Genetic profiling for personalized medicine. Advances in immunotherapy and monoclonal antibodies. Clinical trials for novel drugs and combination therapies. Speaker's Note: Continued research is opening doors to more effective, less invasive treatments. Reference: Nature Reviews Clinical Oncology. Emerging Therapies in Lymphoma Treatment.
Slide 9-

Key Takeaways Cutaneous lymphomas are rare but manageable with early diagnosis. Multimodal treatment approaches improve outcomes. Research holds promise for enhanced care in the future. Speaker's Note: With ongoing advancements, the future for patients with cutaneous lymphomas is brighter than ever. Reference: American Society of Clinical Oncology (ASCO). Cutaneous Lymphoma Overview.
Slide 10-

Thank You